Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.34 |
| ▸ | TDP2 | O95551 | 3/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SLC22A12 | Q96S37 | 5/20 | 0.33 |
| ▸ | CDK4 | P11802 | 1/20 | 0.32 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.32 |
| ▸ | CHUK | O15111 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21758194 | 0.94 | KDM4E (0.39) | KDM4EATML3MBTL1CYP11B1CYP11B2 | |
| SCHEMBL21758161 | 0.93 | KDM4E (0.38) | KDM4EATML3MBTL1CYP11B1CYP11B2 | |
| SCHEMBL21396782 | 0.90 | CYP11B2 (0.38) | CYP11B1CYP11B2CYP19A1SLC22A12CHUK | |
| SCHEMBL21758710 | 0.89 | CYP19A1 (0.34) | KDM4EATML3MBTL1CYP11B1CYP11B2 | |
| SCHEMBL21758709 | 0.89 | CYP19A1 (0.34) | KDM4EATML3MBTL1CYP11B1CYP11B2 | |
| SCHEMBL21758474 | 0.89 | CHUK (0.38) | CYP11B1CYP11B2CYP19A1SLC22A12CHUK | |
| SCHEMBL21758344 | 0.88 | KDM4E (0.38) | KDM4EATML3MBTL1CYP11B1CYP11B2 | |
| SCHEMBL21758708 | 0.85 | CYP11B2 (0.39) | CYP11B1CYP11B2CYP19A1SLC22A12PTGER4 | |
| SCHEMBL21396781 | 0.84 | CYP11B2 (0.39) | CYP11B1CYP11B2CYP19A1SLC22A12CHUK | |
| SCHEMBL21758159 | 0.84 | CYP11B2 (0.37) | CYP11B1CYP11B2SLC22A12CHUKPTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OXER1, OR10J3, OXGR1 | KDM4E 2308/4885ATM 4390/4885L3MBTL1 1426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.